Loading...
Email
Linkedin
Facebook
X
Copy Link
TranscriptThe latest research from The Conference Board shows US consumer confidence declined again in September—a trend C-Suite executives will want to watch. Other global economic trends on the horizon include a possible redux in the US banking crisis due to commercial real estate, a slowdown in China, and increased trade tensions between the US and China. In this episode, Erin McLaughlin, Senior Economist at The Conference Board, and Dana M. Peterson, Chief Economist at The Conference Board, sit down to discuss what this means for the wider economy in the US and abroad.
Tune in to find out:
For more Trusted Insights for What’s Ahead®®:
C-Suite Perspectives is a series hosted by our President & CEO, Steve Odland. This weekly conversation takes an objective, data-driven look at a range of business topics aimed at executives. Listeners will come away with what The Conference Board does best: Trusted Insights for What’s Ahead®.
C-Suite Perspectives provides unique insights for C-Suite executives on timely topics that matter most to businesses as selected by The Conference Board. If you would like to suggest a guest for the podcast series, please email csuite.perspectives@conference-board.org. Note: As a non-profit organization under 501(c)(3) of the IRS Code, The Conference Board cannot promote or offer marketing opportunities to for-profit entities.
C-Suite Perspectives / 04 Aug 2025
More C-Suite leaders view their boards as effective in 2025, but numerous challenges remain, including keeping up with AI.
C-Suite Perspectives / 29 Jul 2025
We break down the latest data from The Conference Board Consumer Confidence Index®, released today.
C-Suite Perspectives / 28 Jul 2025
Learn how Clorox invested in technological innovation so it could continue delivering superior consumer experiences.
C-Suite Perspectives / 21 Jul 2025
2025 is half over. What issues should human capital leaders focus on during the rest of the year?
C-Suite Perspectives / 14 Jul 2025
Learn why culture and constant innovation are essential to developing life-changing biopharma treatments.
C-Suite Perspectives / 07 Jul 2025
We've just passed the midway point of 2025 -- what are the top 10 priorities for chief marketing officers (CMOs) for the rest of the year?
